Dendrimers - Reflections on host-guest interaction mechanism towards solubility enhancement

Asian Journal of Pharmaceutics

Volumn 3, Issue 3, 2009, Pages 188-196

  Jain, Narendra K ^a   Prajapati, Ram N ^a   Agarwal, Abhinav ^a   Gupta, Umesh ^a   Asthana, Abhay ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Dendrimer; Host guest interactions; Solubilization

Indexed keywords

2,4 DICHLOROPHENOXYACETIC ACID; ACETYLSALICYLIC ACID; BARBITURIC ACID; BENZOIC ACID; CISPLATIN; DENDRIMER; DOXORUBICIN; FLUOROURACIL; FLURBIPROFEN; GLUTARIMIDE; IBUPROFEN; INDOMETACIN; LIPOSOME; METHOTREXATE; NAPROXEN; NICOTINIC ACID; NIFEDIPINE; PACLITAXEL; PIROXICAM; PROPRANOLOL; RIFAMPICIN; SALICYLIC ACID; SULFADIAZINE;

AQUEOUS SOLUTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG SOLUBILITY; ENCAPSULATION; HYDROGEN BOND; HYDROPHOBICITY; MICELLE; NONHUMAN; REVIEW;

EID: 77953467054     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.56296     Document Type: Review

References (47)

1. Martin A, Bustamante P, Chun AH. States of Matter. 4th ed. Vol.1. Maryland: Lippincott Williams and Wilkins; 2005. p., 21-23
2. Khalil SA, Abdallah OY, Moustafa MA. The use of solubility parameter as an index of drug activity Canadian J Pharm Sci. 1976;121-126
3. Khalil SA, Martin AN. Drug transport through model membrane and its correlation solubility parameters. J Pharm Sci. 1967;56:1225-1233
4. Adjei A, Newburger J, Stavchansky S, Martin A. Membrane solubility parameter and in-situ release of theophylline. J Pharm Sci 1984;73:742-745
5. Beezer AE, King AS, Martin IK, Mitchel JC, Twyman LJ, Wain CF. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM dendrimers. Tetrahedron 2003;59:3873-3880
6. Park KM, Lee MK, Hwang KJ, Kim CK. Phospholipid based microemulsions of flurbiprofen by the spontaneous emulsification process. J Pharm Sci 1999;183:145-154
7. Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, et al. A new class of polymers: Starburst-dendritic macromolecules. Polymer Journal 1985;17:117-132
8. Patri AK, Kukowska-Latallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: Comparison of the releaser kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 2005;57:2203-2214
9. Liu M, Kono K, Frechet JM. Water soluble dendritic unimolecular micelles: Their potential as drug delivery agents. J Control Release 2000;65:121-131
10. Zeng F, Zimmerman SC. Dendrimers in Supramolecular Chemistry: From Molecular Recognition to Self-Assembly. Chem Rev 1997;97:1681-1712
11. Jain NK, Khopade AJ. Controlled and Novel Drug Delivery. 1st ed. New Delhi: CBS Publishers and Distributors; 2001. p. 361-375
12. Gupta U, Agashe HB, Asthana A, Jain NK. Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 2006;7:649 58.
13. Newkome GR, Moorefield CN, Baker GR, Saunders MJ, Grossman SH. Unimolecular micelles. Angew Chem International Ed Engler 1991;30:1178-1180
14. Naylor AM, Goddard III WA, Kiefer GE, Tomalia DA. Starburst dendrimers: 5. Molecular shape control, Journal of American Chemical Society 1989;111:2339-2341
15. Hawker CJ, Wooley KL, Frechet JM. Unimolecular micelles and globular amphiphiles: Dendritic macromolecules as novel recyclable solubilization agents. Journal Chemical Society Perkin Trans 1997;1:1287-1297
16. D'Emanuel A, Jevprasesphant R, Penny J, Attwood D. The use of a dendrimer propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J Control Release 2004;95:447-453
17. Pistolis G, Malliaris A, Paleos M, Tsiourvas PK. Study of Poly (amidoamine) Starburst Dendrimers by flurorescence probing, Langmuir 1997;13:5870.
18. Kumar PV, Asthana A, Dutta, T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 2006;14:546-556
19. Jansen JF, de Brabander-van den Berg EM, Meijer EW. Encapsulation of Guest Molecules into a Dendritic Box. Science 1994;266:1226-1229
20. Jansen JF, Meijer EW, de Brabander-van den Berg EM. Bengal Rose dendritic box, Macromolecular Symposia 1996;102:27-33.
21. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today 2001;6:427-436
22. Newkome GR, Woosley BD, He E, Morefield CN, Guther R, Baker GR, et al. Supromolecular chemistry of flexible, dendritic-based structure employing molecular recognition, Chemical Communications 1996;2737-2738
23. Prieto MJ, Bacigalupe D, Pardini O, Amalvy JI, Ventarini C, Morilla MJ, et al. Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent. Int J Pharm 2006;326:160-168
24. Twyman LJ, Beezer AE, Esfand R, Hardy MJ, Mitchell JC. The synthesis of water-soluble dendrimers, and their application as possible drug delivery systems. Tetrahedron Letters 1999;40:1743-1746
25. Chauhan AS, Jain NK, Diwan PV, Khopade AJ. Solubility enhancement of indomethacin with poly (amidoamine) dendrimers and targeting to inflammatory regions of arthritic rats. J Drug Target 2004;12:575-583
26. Wiwattanapatapee R, Jee RD, Duncan R. PAMAM dendrimers as potential oral drug delivery systems dendrimer complexes with piroxicam. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 1999;26:241.
27. Yang H, Morris JJ, Lopina ST. Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. J Colloid Interface Sci 2004;273:148-154
28. Yiyun C, Tongwen X. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Eur J Med Chem 2005;40:1384-1389
29. Devarakonda B, Hill RA, De Villiers MM. The effect of PAMAM dendrimer generation size and surface functional groups on the aqueous solubility of nifedipine. Int J Pharm 2004;284:133-140
30. Santo M, Fox MA. Hydrogen bonding interactions between starburst dendrimers and several molecules of biological interest. Journal of Physical Organic Chemistry 1999;12:293.
31. Milhem OM, Myles C, McKeown NB, Attwood D, D'Emanuele A. Polyamidoamine Starburst dendrimers as solubility enhancers. Int J Pharm 2000;197:239-241
32. Baars ML, Kleppinger R, Koch MJ, Yeu SL, Miejer EW. The Localization of Guests in Water-Soluble Oligoethyleneoxy-Modified Poly (propylene imine) Dendrimers This work was supported by the Netherlands Foundation for Chemical Research (CW), with financial aid from the Netherlands Organisation for Scientific Research (NWO). The authors thank Stefan Meskers, Harry Dekkers, Marcel van Genderen, and Rint Sijbesma for stimulating discussions. DSM Research is acknowleged for providing the poly(propyleneimine) dendrimers. M.B. and R.K. acknowledge financial support under the TMR/LSF program of the European Union (No.ERBFMGECT980134) to the EMBL Hamburg outstation. Angew Chem Int Ed Engl 2000;39:1285-1288
33. Kolhe P, Khandare J, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Preparation, cellular transport, and activity of polyamidoamine- based dendritic nanodevices with a high drug payload. Biomaterials 2006;27:660-669
34. Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, et al. Dendrimer mediated transdermal delivery: Enhanced bioavailability of indomethacin. J Control Release 2003;90:335-343
35. Namazi H, Adeli M. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials 2005;26:1175-1183
36. Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) dendritic nano-structures for controlled site-specific delivery of anti- inflammatory active ingredient. AAPS Pharm Science Tech 2005;6:536-542
37. Najlah M, Freeman S, Attwood D, D'Emanuele A. Synthesis, characterization and stability of dendrimer prodrugs. Int J Pharm 2006;308:175-182
38. Yiyun C, Tongwen X. Dendrimers as potential drug carriers part I solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur J Med Chem 2005;40:1188-1192
39. Kolhe P, Misra E, Kannan RM, Kannan S, Lieh-Lai M. Drug complexation in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm 2003;259:143-160
40. Duncan R, Malik N. Dendrimers: Biocompalibility and potential for delivery of anticancer agents. Proceedings of the International Symposia on Control Release Bioactive Materials 1996;23:105-106
41. Zhuo RX, Du B, Lu ZR. In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release 1999;57:244-257
42. Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 2002;232:157-162
43. Purohit G, Sakthivel T, Florence AT. Interaction of cationic partial dendrimers with charged and neutral liposomes. Int J Pharm 2001;214:71-76
44. Al-Jamal KT, Sakthivel T, Florence AT. Dendriosomes: Cationic lipodic dendron vesicular assemblies. Int J Pharm 2003;254:33-36
45. Ooya T, Lee J, Park K. Effects of ethylene glycol based grafts, star shaped and dendritic polymers on solubilization and controlled release of Paclitaxel. J Control Release 2003;93:121-127
46. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamido- amine dendrimers having poly(ethyleneglycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 2000;11:910-917
47. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil., Int J Pharm 2003;257:,111-124